日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Effects of Anti-thyroid Drugs on Lipoproteins and Insulin Resistance in Graves' Disease: A Randomized Clinical Trial

抗甲状腺药物对格雷夫斯病患者脂蛋白和胰岛素抵抗的影响:一项随机临床试验

Wisnu, Wismandari; Alwi, Idrus; Nafrialdi, Nafrialdi; Pemayun, Tjokorda Gde Dalem; Pantoro, Nico Iswanto; Wijaya, Calysta Nadya; Tahapary, Dicky Levenus; Tarigan, Tri Juli Edi; Subekti, Imam

The role of the glucocorticoid receptor and its impact on steroid response in moderate-severe COVID-19 patients

糖皮质激素受体的作用及其对中重度 COVID-19 患者类固醇反应的影响

Aliska, Gestina; Nafrialdi, Nafrialdi; Lie, Khie Chen; Setiabudy, Rianto; Putra, Andani Eka; Widyahening, Indah Suci; Harahap, Alida Roswita

Analysis of Intoxication, Rehospitalization, and One-year Survival of Heart Failure Patients Receiving Digoxin at Harapan Kita National Cardiovascular Center, Jakarta, Indonesia: A Cross Section-observational Study

印度尼西亚雅加达哈拉潘基塔国家心血管中心接受地高辛治疗的心力衰竭患者的中毒、再入院和一年生存率分析:一项横断面观察研究

Nafrialdi, Nafrialdi; Tiaranita, Cindy; Suyatna, Fransiscus D; Siswanto, Bambang Budi

Protective effects of silver nanoparticles in isoproterenol-induced myocardial infarction in rats

银纳米粒子对异丙肾上腺素诱发大鼠心肌梗死的保护作用

Wawaimuli Arozal, Edwina Rogayah Monayo, Agian Jeffilano Barinda, Dian Pribadi Perkasa, Vivian Soetikno, Nafrialdi Nafrialdi, Melva Louisa

The Differential Effects of Propylthiouracil and Methimazole as Graves' Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial.

丙硫氧嘧啶和甲巯咪唑作为格雷夫斯病治疗药物对血管动脉粥样硬化标志物的不同影响:一项随机临床试验

Wisnu Wismandari, Alwi Idrus, Nafrialdi Nafrialdi, Harimurti Kuntjoro, Pemayun Tjokorda Gede D, Jusman Sri Widia A, Santoso Dewi Irawati S, Harahap Alida R, Suwarto Suhendro, Subekti Imam